Expanding the efficacy of Project UPLIFT: Distance delivery of mindfulness-based depression prevention to people with epilepsy.
Study Goal
The researchers aimed to evaluate the efficacy of mindfulness-based cognitive therapy (Project UPLIFT) in preventing major depressive disorder episodes and reducing depressive symptoms in people with epilepsy.
Results Summary
The intervention significantly reduced the incidence of MDD episodes (0.0% vs. 10.7% in the control group), decreased depressive symptoms, and increased life satisfaction. The effects were mediated by improved knowledge/skills and persisted over a 10-week follow-up.
Population
Adults with epilepsy and mild/moderate depressive symptoms from Georgia, Michigan, Texas, and Washington.
Effective Dosage
8 weekly sessions of group-delivered mindfulness-based cognitive therapy (Web or telephone).
Duration
8 weeks (with follow-up assessments at ~10 and ~20 weeks).
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Project UPLIFT intervention, based on mindfulness-based cognitive therapy | decrease | incidence of MDD episodes (new or relapse) | adults with epilepsy and mild/moderate depressive symptoms | 0.0% in intervention vs 10.7% in TAU | significantly lower | #1 |
Project UPLIFT intervention, based on mindfulness-based cognitive therapy | decrease | depressive symptoms | adults with epilepsy and mild/moderate depressive symptoms | - | decreased significantly more | #2 |
Project UPLIFT intervention, based on mindfulness-based cognitive therapy | increase | knowledge/skills | adults with epilepsy and mild/moderate depressive symptoms | - | increased significantly more | #3 |
Project UPLIFT intervention, based on mindfulness-based cognitive therapy | increase | life satisfaction | adults with epilepsy and mild/moderate depressive symptoms | - | increased significantly more | #4 |
Distance delivery of group mindfulness-based cognitive therapy | decrease | episodes of MDD | people with epilepsy | - | can prevent episodes | #5 |
Distance delivery of group mindfulness-based cognitive therapy | decrease | symptoms of depression | people with epilepsy | - | reduce symptoms | #6 |
Distance delivery of group mindfulness-based cognitive therapy | increase | life satisfaction | people with epilepsy | - | increase | #7 |
OBJECTIVE: Depression affects about 16% of the U.S. population over a lifetime. People with chronic diseases have especially high rates of comorbid depression; 32% to 48% of people with epilepsy experience depression. This study evaluated the efficacy of a mindfulness-based cognitive therapy intervention for preventing major depressive disorder (MDD) episodes in people with epilepsy. METHOD: Participants (n = 128) were adults from Georgia, Michigan, Texas, and Washington with epilepsy and mild/moderate depressive symptoms. The 8-session weekly Project UPLIFT intervention, based on mindfulness-based cognitive therapy, was group-delivered via Web or telephone. Using a randomized, controlled crossover design, participants were assigned to Project UPLIFT or a treatment-as-usual (TAU) waitlist and assessed at baseline, and after intervening in the intervention group (∼10 weeks) and in the TAU group (∼20 weeks). Assessments included valid self-report measures of depression and MDD, knowledge/skills, and satisfaction with life. RESULTS: The incidence of MDD episodes (new or relapse) from baseline to interim assessment was significantly lower in the intervention condition (0.0%) than in TAU (10.7%). Depressive symptoms decreased significantly more in the intervention condition than in TAU; Web and telephone did not differ. Change in knowledge/skills mediated the effect, which persisted over the 10 weeks of follow-up. Knowledge/skills and life satisfaction increased significantly more in the intervention condition than in TAU. CONCLUSIONS: Distance delivery of group mindfulness-based cognitive therapy can prevent episodes of MDD, reduce symptoms of depression, and increase life satisfaction in people with epilepsy. This intervention is easily modified for persons with other chronic diseases and other disparity populations. (PsycINFO Database Record